| Pos |
No. |
Sex |
Age |
Organ |
Pathology diagnosis |
Grade |
Stage |
TNM |
Type † |
| A1 |
1 |
M |
59 |
Stomach |
Adenocarcinoma |
1 |
II |
T3N0M0 |
Malignant |
| A2 |
2 |
M |
67 |
Stomach |
Adenocarcinoma |
3 |
Ib |
T2N0M0 |
Malignant |
| A3 |
3 |
M |
66 |
Stomach |
Adenocarcinoma |
1 |
III |
T3NxM0 |
Malignant |
| A4 |
4 |
M |
56 |
Stomach |
Adenocarcinoma |
2 |
Ib |
T2N0M0 |
Malignant |
| A5 |
5 |
M |
56 |
Stomach |
Adenocarcinoma |
2 |
Ib |
T2N0M0 |
Malignant |
| A6 |
6 |
M |
61 |
Stomach |
Adenocarcinoma |
2 |
Ib |
T2N0M0 |
Malignant |
| A7 |
7 |
M |
60 |
Stomach |
Adenocarcinoma |
2 |
Ib |
T2N0M0 |
Malignant |
| A8 |
8 |
M |
61 |
Stomach |
Adenocarcinoma |
2 |
Ib |
T2N0M0 |
Malignant |
| A9 |
9 |
F |
60 |
Stomach |
Adenocarcinoma |
2 |
Ib |
T2N0M0 |
Malignant |
| A10 |
10 |
M |
64 |
Stomach |
Adenocarcinoma |
1 |
II |
T3N0M0 |
Malignant |
| A11 |
11 |
F |
55 |
Stomach |
Adenocarcinoma |
2 |
Ib |
T2N0M0 |
Malignant |
| A12 |
12 |
F |
72 |
Stomach |
Adenocarcinoma |
2 |
II |
T3N0M0 |
Malignant |
| A13 |
13 |
F |
51 |
Stomach |
Adenocarcinoma |
2 |
Ib |
T2N0M0 |
Malignant |
| A14 |
14 |
M |
68 |
Stomach |
Adenocarcinoma |
2 |
II |
T3N0M0 |
Malignant |
| A15 |
15 |
M |
94 |
Stomach |
Adenocarcinoma |
3 |
Ib |
T2N0M0 |
Malignant |
| A16 |
16 |
M |
73 |
Stomach |
Adenocarcinoma |
2 |
Ib |
T2N0M0 |
Malignant |
| B1 |
17 |
F |
50 |
Stomach |
Adenocarcinoma |
2 |
Ib |
T2N0M0 |
Malignant |
| B2 |
18 |
M |
57 |
Stomach |
Adenocarcinoma |
2 |
II |
T3N0M0 |
Malignant |
| B3 |
19 |
M |
66 |
Stomach |
Adenocarcinoma |
2 |
Ib |
T2N0M0 |
Malignant |
| B4 |
20 |
M |
69 |
Stomach |
Adenocarcinoma |
3 |
Ib |
T2N0M0 |
Malignant |
| B5 |
21 |
F |
47 |
Stomach |
Adenocarcinoma |
3 |
Ib |
T3N1M0 |
Malignant |
| B6 |
22 |
M |
60 |
Stomach |
Adenocarcinoma |
3 |
IIIa |
T3N0M0 |
Malignant |
| B7 |
23 |
M |
64 |
Stomach |
Adenocarcinoma |
3 |
II |
T2N1M0 |
Malignant |
| B8 |
24 |
M |
75 |
Stomach |
Adenocarcinoma |
3 |
Ib |
T2N0M0 |
Malignant |
| B9 |
25 |
M |
70 |
Stomach |
Adenocarcinoma |
3 |
Ib |
T2N0M0 |
Malignant |
| B10 |
26 |
M |
58 |
Stomach |
Adenocarcinoma |
2–3 |
II |
T2N1M0 |
Malignant |
| B11 |
27 |
F |
45 |
Stomach |
Adenocarcinoma |
3 |
IV |
T4N0M1 |
Malignant |
| B12 |
28 |
M |
56 |
Stomach |
Adenocarcinoma |
3 |
Ib |
T2N0M0 |
Malignant |
| B13 |
29 |
M |
32 |
Stomach |
Adenocarcinoma |
3 |
Ib |
T2N0M0 |
Malignant |
| B14 |
30 |
M |
58 |
Stomach |
Mucinous adenocarcinoma |
2 |
Ib |
T2N0M0 |
Malignant |
| B15 |
31 |
M |
82 |
Stomach |
Adenocarcinoma |
2 |
Ib |
T2N0M0 |
Malignant |
| B16 |
32 |
M |
49 |
Stomach |
Adenocarcinoma |
3 |
Ib |
T2N0M0 |
Malignant |
| C1 |
33 |
M |
59 |
Stomach |
Mucinous adenocarcinoma |
3 |
Ia |
T1N0M0 |
Malignant |
| C2 |
34 |
F |
47 |
Stomach |
Adenocarcinoma |
3 |
Ib |
T2N0M0 |
Malignant |
| C3 |
35 |
F |
66 |
Stomach |
Adenocarcinoma |
3 |
Ib |
T3N0M0 |
Malignant |
| C4 |
36 |
M |
60 |
Stomach |
Adenocarcinoma |
3 |
Ib |
T2N0M0 |
Malignant |
| C5 |
37 |
M |
65 |
Stomach |
Adenocarcinoma |
3 |
IIIa |
T4N0M0 |
Malignant |
| C6 |
38 |
M |
40 |
Stomach |
Adenocarcinoma |
3 |
IIIa |
T4N0M0 |
Malignant |
| C7 |
39 |
M |
58 |
Stomach |
Undifferentiated adenocarcinoma |
4 |
Ib |
T2N0M0 |
Malignant |
| C8 |
40 |
F |
61 |
Stomach |
Undifferentiated adenocarcinoma |
4 |
Ib |
T2N0M0 |
Malignant |
| C9 |
41 |
F |
48 |
Liver |
Hepatocellular carcinoma |
1 |
III |
T3N0M0 |
Malignant |
| C10 |
42 |
F |
62 |
Liver |
Hepatocellular carcinoma |
2 |
III |
T3N0M0 |
Malignant |
| C11 |
43 |
M |
68 |
Liver |
Hepatocellular carcinoma |
2 |
III |
T3N0M0 |
Malignant |
| C12 |
44 |
M |
62 |
Liver |
Hepatocellular carcinoma |
2 |
I |
T1N0M0 |
Malignant |
| C13 |
45 |
M |
45 |
Liver |
Hepatocellular carcinoma |
2 |
II |
T2N0M0 |
Malignant |
| C14 |
46 |
M |
65 |
Liver |
Hepatocellular carcinoma |
2 |
II |
T2N0M0 |
Malignant |
| C15 |
47 |
M |
43 |
Liver |
Hepatocellular carcinoma |
2 |
III |
T3N0M0 |
Malignant |
| C16 |
48 |
M |
49 |
Liver |
Hepatocellular carcinoma |
2 |
II |
T2N0M0 |
Malignant |
| D1 |
49 |
M |
49 |
Liver |
Hepatocellular carcinoma |
2 |
II |
T2N0M0 |
Malignant |
| D2 |
50 |
M |
46 |
Liver |
Hepatocellular carcinoma |
2 |
III |
T3N0M0 |
Malignant |
| D3 |
51 |
M |
40 |
Liver |
Hepatocellular carcinoma |
2 |
III |
T3N0M0 |
Malignant |
| D4 |
52 |
M |
35 |
Liver |
Hepatocellular carcinoma |
2 |
III |
T3N0M0 |
Malignant |
| D5 |
53 |
F |
65 |
Liver |
Hepatocellular carcinoma |
2 |
II |
T2N0M0 |
Malignant |
| D6 |
54 |
F |
64 |
Liver |
Hepatocellular carcinoma |
2 |
III |
T3N0M0 |
Malignant |
| D7 |
55 |
F |
49 |
Liver |
Hepatocellular carcinoma |
2 |
II |
T2N0M0 |
Malignant |
| D8 |
56 |
M |
70 |
Liver |
Hepatocellular carcinoma |
2 |
III |
T3N0M0 |
Malignant |
| D9 |
57 |
M |
46 |
Liver |
Hepatocellular carcinoma |
2 |
III |
T3N0M0 |
Malignant |
| D10 |
58 |
M |
58 |
Liver |
Hepatocellular carcinoma |
2 |
III |
T3N0M0 |
Malignant |
| D11 |
59 |
F |
52 |
Liver |
Hepatocellular carcinoma |
2 |
III |
T3N0M0 |
Malignant |
| D12 |
60 |
M |
40 |
Liver |
Hepatocellular carcinoma |
2 |
II |
T2N0M0 |
Malignant |
| D13 |
61 |
M |
56 |
Liver |
Hepatocellular carcinoma with necrosis |
3 |
III |
T3N0M0 |
Malignant |
| D14 |
62 |
M |
42 |
Liver |
Hepatocellular carcinoma |
3 |
IVa |
T4N0M0 |
Malignant |
| D15 |
63 |
F |
62 |
Liver |
Hepatocellular carcinoma |
3 |
III |
T3N0M0 |
Malignant |
| D16 |
64 |
F |
52 |
Liver |
Hepatocellular carcinoma |
2 |
III |
T3N0M0 |
Malignant |
| E1 |
65 |
M |
52 |
Liver |
Hepatocellular carcinoma |
3 |
III |
T3N0M0 |
Malignant |
| E2 |
66 |
M |
45 |
Liver |
Hepatocellular carcinoma |
1 |
II |
T2N0M0 |
Malignant |
| E3 |
67 |
M |
45 |
Liver |
Hepatocellular carcinoma |
2 |
II |
T2N0M0 |
Malignant |
| E4 |
68 |
M |
63 |
Liver |
Hepatocellular carcinoma |
3 |
II |
T2N0M0 |
Malignant |
| E5 |
69 |
M |
47 |
Liver |
Hepatocellular carcinoma |
3 |
III |
T3N0M0 |
Malignant |
| E6 |
70 |
F |
47 |
Liver |
Hepatocellular carcinoma (fatty degeneration of liver) |
- |
III |
T3N0M0 |
Malignant |
| E7 |
71 |
M |
35 |
Liver |
Hepatocellular carcinoma |
2 |
III |
T3N0M0 |
Malignant |
| E8 |
72 |
M |
41 |
Liver |
Hepatocellular carcinoma |
2 |
III |
T3N0M0 |
Malignant |
| E9 |
73 |
M |
35 |
Liver |
Hepatocellular carcinoma |
3 |
II |
T2N0M0 |
Malignant |
| E10 |
74 |
F |
68 |
Liver |
Hepatocellular carcinoma |
3 |
II |
T2N0M0 |
Malignant |
| E11 |
75 |
M |
46 |
Liver |
Hepatocellular carcinoma |
3 |
III |
T3N0M0 |
Malignant |
| E12 |
76 |
F |
69 |
Liver |
Hepatocellular carcinoma |
2 |
III |
T3N0M0 |
Malignant |
| E13 |
77 |
M |
38 |
Liver |
Hepatocellular carcinoma |
3 |
III |
T3N0M0 |
Malignant |
| E14 |
78 |
M |
64 |
Liver |
Hepatocellular carcinoma |
3 |
II |
T2N0M0 |
Malignant |
| E15 |
79 |
F |
46 |
Liver |
Hepatocellular carcinoma |
3 |
III |
T3N0M0 |
Malignant |
| E16 |
80 |
F |
55 |
Liver |
Hepatocellular carcinoma |
2 |
III |
T3N0M0 |
Malignant |
| F1 |
81 |
F |
46 |
Ovary |
Mucinous adenocarcinoma |
2 |
I |
T1N0M0 |
Malignant |
| F2 |
82 |
F |
57 |
Ovary |
Serous adenocarcinoma |
2 |
Ib |
T1bN0M0 |
Malignant |
| F3 |
83 |
F |
41 |
Ovary |
Serous adenocarcinoma |
1 |
Ia |
T1aN0M0 |
Malignant |
| F4 |
84 |
F |
26 |
Ovary |
Serous adenocarcinoma |
1 |
Ia |
T1aN0M0 |
Malignant |
| F5 |
85 |
F |
32 |
Ovary |
Mucinous adenocarcinoma (mucous tissue) |
- |
I |
T1N0M0 |
Malignant |
| F6 |
86 |
F |
25 |
Ovary |
Serous papillary adenocarcinoma |
1 |
Ia |
T1aN0M0 |
Malignant |
| F7 |
87 |
F |
48 |
Ovary |
Mucinous adenocarcinoma |
1 |
I |
T1N0M0 |
Malignant |
| F8 |
88 |
F |
48 |
Ovary |
Serous adenocarcinoma |
1 |
Ia |
T1aN0M0 |
Malignant |
| F9 |
89 |
F |
49 |
Ovary |
Clear cell carcinoma |
1–2 |
I |
T1N0M0 |
Malignant |
| F10 |
90 |
F |
60 |
Ovary |
Endometrioid adenocarcinoma |
2 |
II |
T2N0M0 |
Malignant |
| F11 |
91 |
F |
56 |
Ovary |
Serous adenocarcinoma (fibrous hyalinosis and blood vessel tissue) |
- |
Ib |
T1bN0M0 |
Malignant |
| F12 |
92 |
F |
24 |
Ovary |
Mucinous adenocarcinoma |
1 |
Ia |
T1aN0M0 |
Malignant |
| F13 |
93 |
F |
73 |
Ovary |
Serous adenocarcinoma |
3 |
Ib |
T1bN0M0 |
Malignant |
| F14 |
94 |
F |
49 |
Ovary |
Serous adenocarcinoma |
2 |
Ia |
T1aN0M0 |
Malignant |
| F15 |
95 |
F |
56 |
Ovary |
Mucinous adenocarcinoma |
3 |
Ib |
T1bN0M0 |
Malignant |
| F16 |
96 |
F |
66 |
Ovary |
Serous adenocarcinoma |
2 |
IIIa |
T3aN0M0 |
Malignant |
| G1 |
97 |
F |
64 |
Ovary |
Serous papillary adenocarcinoma |
2 |
Ia |
T1aN0M0 |
Malignant |
| G2 |
98 |
F |
57 |
Ovary |
Serous papillary adenocarcinoma |
2 |
Ic |
T1cN0M0 |
Malignant |
| G3 |
99 |
F |
48 |
Ovary |
Mucinous adenocarcinoma |
3 |
Ia |
T1aN0M0 |
Malignant |
| G4 |
100 |
F |
69 |
Ovary |
Serous adenocarcinoma |
2 |
II |
T2N0M0 |
Malignant |
| G5 |
101 |
F |
55 |
Ovary |
Serous papillary adenocarcinoma |
2 |
Ia |
T1aN0M0 |
Malignant |
| G6 |
102 |
F |
57 |
Ovary |
Serous adenocarcinoma |
3 |
Ia |
T1aN0M0 |
Malignant |
| G7 |
103 |
F |
47 |
Ovary |
Serous adenocarcinoma |
3 |
Ia |
T1aN0M0 |
Malignant |
| G8 |
104 |
F |
52 |
Ovary |
Serous papillary adenocarcinoma |
2 |
Ia |
T1aN0M0 |
Malignant |
| G9 |
105 |
F |
57 |
Ovary |
Serous adenocarcinoma |
3 |
Ib |
T1bN0M0 |
Malignant |
| G10 |
106 |
F |
53 |
Ovary |
Serous adenocarcinoma |
2 |
Ia |
T1aN0M0 |
Malignant |
| G11 |
107 |
F |
57 |
Ovary |
Serous adenocarcinoma |
3 |
III |
T3N0M0 |
Malignant |
| G12 |
108 |
F |
58 |
Ovary |
Serous adenocarcinoma |
3 |
Ia |
T1aN0M0 |
Malignant |
| G13 |
109 |
F |
57 |
Ovary |
Serous adenocarcinoma |
3 |
Ic |
T1cN0M0 |
Malignant |
| G14 |
110 |
F |
45 |
Ovary |
Serous adenocarcinoma |
3 |
Ia |
T1aN0M0 |
Malignant |
| G15 |
111 |
F |
55 |
Ovary |
Serous adenocarcinoma |
3 |
Ia |
T1aN0M0 |
Malignant |
| G16 |
112 |
F |
56 |
Ovary |
Serous adenocarcinoma |
3 |
II |
T2N0M0 |
Malignant |
| H1 |
113 |
F |
54 |
Ovary |
Serous adenocarcinoma |
3 |
II |
T2N0M0 |
Malignant |
| H2 |
114 |
F |
48 |
Ovary |
Serous adenocarcinoma |
3 |
IV |
T3cN1M1 |
Malignant |
| H3 |
115 |
F |
50 |
Ovary |
Serous adenocarcinoma |
3 |
IIIc |
T3N1M0 |
Malignant |
| H4 |
116 |
F |
39 |
Ovary |
Serous adenocarcinoma with necrosis |
3 |
II |
T2N0M0 |
Malignant |
| H5 |
117 |
F |
40 |
Ovary |
Serous adenocarcinoma (sparse) |
2 |
I |
T1N0M0 |
Malignant |
| H6 |
118 |
F |
52 |
Ovary |
Serous adenocarcinoma |
3 |
Ic |
T1cN0M0 |
Malignant |
| H7 |
119 |
F |
55 |
Ovary |
Serous adenocarcinoma |
3 |
Ib |
T1bN0M0 |
Malignant |
| H8 |
120 |
F |
56 |
Ovary |
Serous adenocarcinoma |
3 |
II |
T2N0M0 |
Malignant |
| H9 |
121 |
F |
40 |
Uterus |
Endometrioid adenocarcinoma |
1 |
II |
T2N0M0 |
Malignant |
| H10 |
122 |
F |
61 |
Uterus |
Endometrioid adenocarcinoma |
1 |
Ic |
T1cN0M0 |
Malignant |
| H11 |
123 |
F |
40 |
Uterus |
Endometrioid adenocarcinoma |
1 |
Ib |
T1bN0M0 |
Malignant |
| H12 |
124 |
F |
51 |
Uterus |
Endometrioid adenocarcinoma |
1 |
Ia |
T1aN0M0 |
Malignant |
| H13 |
125 |
F |
65 |
Uterus |
Endometrioid adenocarcinoma |
2 |
Ia |
T1aN0M0 |
Malignant |
| H14 |
126 |
F |
62 |
Uterus |
Endometrioid adenocarcinoma |
1 |
Ic |
T1cN0M0 |
Malignant |
| H15 |
127 |
F |
57 |
Uterus |
Endometrioid adenocarcinoma |
2 |
Ic |
T1cN0M0 |
Malignant |
| H16 |
128 |
F |
65 |
Uterus |
Endometrioid adenocarcinoma |
2 |
IIb |
T2bN0M0 |
Malignant |
| I1 |
129 |
F |
50 |
Uterus |
Endometrioid adenocarcinoma |
2 |
Ib |
T1bN0M0 |
Malignant |
| I2 |
130 |
F |
50 |
Uterus |
Endometrioid adenocarcinoma |
2 |
Ib |
T1bN0M0 |
Malignant |
| I3 |
131 |
F |
53 |
Uterus |
Endometrioid adenocarcinoma |
2 |
Ib |
T1bN0M0 |
Malignant |
| I4 |
132 |
F |
40 |
Uterus |
Endometrioid adenocarcinoma |
2 |
IIa |
T2aN0M0 |
Malignant |
| I5 |
133 |
F |
51 |
Uterus |
Endometrioid adenocarcinoma |
2 |
Ib |
T1bN0M0 |
Malignant |
| I6 |
134 |
F |
35 |
Uterus |
Endometrioid adenocarcinoma |
2 |
IIb |
T2bN0M0 |
Malignant |
| I7 |
135 |
F |
58 |
Uterus |
Endometrioid adenocarcinoma |
2 |
Ic |
T1cN0M0 |
Malignant |
| I8 |
136 |
F |
61 |
Uterus |
Endometrioid adenocarcinoma |
2 |
Ib |
T1bN0M0 |
Malignant |
| I9 |
137 |
F |
62 |
Uterus |
Endometrioid adenocarcinoma |
2 |
Ib |
T1bN0M0 |
Malignant |
| I10 |
138 |
F |
30 |
Uterus |
Endometrioid adenocarcinoma |
2 |
Ic |
T1cN0M0 |
Malignant |
| I11 |
139 |
F |
65 |
Uterus |
Endometrioid adenocarcinoma |
2 |
Ic |
T1cN0M0 |
Malignant |
| I12 |
140 |
F |
40 |
Uterus |
Endometrioid adenocarcinoma |
2 |
Ib |
T1bN0M0 |
Malignant |
| I13 |
141 |
F |
68 |
Uterus |
Endometrioid adenocarcinoma |
2 |
Ic |
T1cN0M0 |
Malignant |
| I14 |
142 |
F |
55 |
Uterus |
Endometrioid adenocarcinoma |
2 |
Ic |
T1cN0M0 |
Malignant |
| I15 |
143 |
F |
57 |
Uterus |
Endometrioid adenocarcinoma |
2 |
Ic |
T1cN0M0 |
Malignant |
| I16 |
144 |
F |
52 |
Uterus |
Endometrioid adenocarcinoma |
2 |
Ib |
T1bN0M0 |
Malignant |
| J1 |
145 |
F |
64 |
Uterus |
Endometrioid adenocarcinoma |
2–3 |
Ib |
T1bN0M0 |
Malignant |
| J2 |
146 |
F |
59 |
Uterus |
Endometrioid adenocarcinoma (sparse) |
2 |
Ic |
T1cN0M0 |
Malignant |
| J3 |
147 |
F |
52 |
Uterus |
Endometrioid adenocarcinoma |
2 |
Ic |
T1cN0M0 |
Malignant |
| J4 |
148 |
F |
50 |
Uterus |
Endometrioid adenocarcinoma |
2 |
IIb |
T2bN0M0 |
Malignant |
| J5 |
149 |
F |
56 |
Uterus |
Endometrioid adenocarcinoma |
2 |
I |
T1N0M0 |
Malignant |
| J6 |
150 |
F |
57 |
Uterus |
Endometrioid adenocarcinoma |
2 |
Ic |
T1cN0M0 |
Malignant |
| J7 |
151 |
F |
45 |
Uterus |
Endometrioid adenocarcinoma |
3 |
Ib |
T1bN0M0 |
Malignant |
| J8 |
152 |
F |
48 |
Uterus |
Endometrioid adenocarcinoma |
2 |
IIa |
T2N0M0 |
Malignant |
| J9 |
153 |
F |
60 |
Uterus |
Endometrioid adenocarcinoma |
3 |
Ic |
T1cN0M0 |
Malignant |
| J10 |
154 |
F |
64 |
Uterus |
Endometrioid adenocarcinoma |
3 |
Ib |
T1bN0M0 |
Malignant |
| J11 |
155 |
F |
57 |
Uterus |
Endometrioid adenocarcinoma |
3 |
Ic |
T1cN0M0 |
Malignant |
| J12 |
156 |
F |
53 |
Uterus |
Endometrioid adenocarcinoma |
3 |
Ic |
T1cN0M0 |
Malignant |
| J13 |
157 |
F |
56 |
Uterus |
Endometrioid adenocarcinoma |
3 |
IIa |
T2aN0M0 |
Malignant |
| J14 |
158 |
F |
47 |
Uterus |
Endometrioid adenocarcinoma |
3 |
IIIa |
T3aN0M0 |
Malignant |
| J15 |
159 |
F |
55 |
Uterus |
Endometrioid adenocarcinoma |
3 |
Ib |
T1bN0M0 |
Malignant |
| J16 |
160 |
F |
63 |
Uterus |
Endometrioid adenocarcinoma |
3 |
Ia |
T1aN0M0 |
Malignant |
| K1 |
161 |
M |
77 |
Cheek |
Squamous cell carcinoma of right cheek |
1 |
III |
T3N0M0 |
Malignant |
| K2 |
162 |
M |
40 |
Upper jaw |
Squamous cell carcinoma of gingiva |
1 |
IV |
T4N0M0 |
Malignant |
| K3 |
163 |
M |
81 |
Lip |
Squamous cell carcinoma of lip |
1 |
II |
T2N0M0 |
Malignant |
| K4 |
164 |
F |
51 |
Cheek |
Squamous cell carcinoma of left cheek |
1 |
IV |
T4N0M0 |
Malignant |
| K5 |
165 |
M |
52 |
Gingiva |
Squamous cell carcinoma of left gingiva |
1 |
I |
T1N0M0 |
Malignant |
| K6 |
166 |
M |
49 |
Upper jaw |
Squamous cell carcinoma of left upper jaw |
1 |
IV |
T4N0M0 |
Malignant |
| K7 |
167 |
M |
54 |
Larynx |
Squamous cell carcinoma of larynx |
1 |
III |
T3N0M0 |
Malignant |
| K8 |
168 |
M |
56 |
Larynx |
Squamous cell carcinoma of larynx |
1 |
IV |
T4N0M0 |
Malignant |
| K9 |
169 |
M |
58 |
Larynx |
Squamous cell carcinoma of larynx |
1 |
III |
T3N0M0 |
Malignant |
| K10 |
170 |
M |
65 |
Larynx |
Squamous cell carcinoma of larynx |
2 |
II |
T2N0M0 |
Malignant |
| K11 |
171 |
M |
66 |
Larynx |
Squamous cell carcinoma of larynx |
1 |
II |
T2N0M0 |
Malignant |
| K12 |
172 |
M |
61 |
Larynx |
Squamous cell carcinoma of larynx |
1 |
III |
T3N0M0 |
Malignant |
| K13 |
173 |
M |
60 |
Larynx |
Squamous cell carcinoma of larynx |
1 |
IV |
T4N0M0 |
Malignant |
| K14 |
174 |
M |
50 |
Larynx |
Squamous cell carcinoma of larynx |
2 |
IV |
T4N0M0 |
Malignant |
| K15 |
175 |
M |
61 |
Larynx |
Squamous cell carcinoma of larynx |
2 |
III |
T3N0M0 |
Malignant |
| K16 |
176 |
M |
60 |
Tongue |
Squamous cell carcinoma of tongue |
2 |
I |
T1N0M0 |
Malignant |
| L1 |
177 |
M |
60 |
Larynx |
Squamous cell carcinoma of larynx |
2 |
III |
T3N0M0 |
Malignant |
| L2 |
178 |
M |
47 |
Nose |
Squamous cell carcinoma of nasal sinuses |
2 |
II |
T2N0M0 |
Malignant |
| L3 |
179 |
M |
42 |
Nose |
Squamous cell carcinoma (sparse) of nasal cavity |
2 |
I |
T1N0M0 |
Malignant |
| L4 |
180 |
M |
62 |
Nose |
Squamous cell carcinoma (sparse) with necrosis of maxillary sinus |
- |
IV |
T4N0M0 |
Malignant |
| L5 |
181 |
M |
70 |
Nose |
Squamous cell carcinoma of left maxillary sinus |
2 |
II |
T2N0M0 |
Malignant |
| L6 |
182 |
M |
57 |
Tongue |
Squamous cell carcinoma of tongue |
2 |
I |
T1N0M0 |
Malignant |
| L7 |
183 |
F |
61 |
Mandible |
Squamous cell carcinoma of left mandible |
2 |
II |
T2N0M0 |
Malignant |
| L8 |
184 |
M |
75 |
Nose |
Squamous cell carcinoma of maxillary sinus |
2 |
IV |
T4N0M0 |
Malignant |
| L9 |
185 |
M |
64 |
Larynx |
Squamous cell carcinoma of larynx |
2 |
IV |
T4N1M0 |
Malignant |
| L10 |
186 |
M |
52 |
Larynx |
Squamous cell carcinoma of larynx |
2 |
III |
T3N0M0 |
Malignant |
| L11 |
187 |
M |
60 |
Larynx |
Squamous cell carcinoma of larynx |
3 |
III |
T3N0M0 |
Malignant |
| L12 |
188 |
M |
43 |
Maxilla |
Squamous cell carcinoma of maxilla |
3 |
II |
T2N0M0 |
Malignant |
| L13 |
189 |
M |
57 |
Lip |
Squamous cell carcinoma (sparse) of lower lip |
- |
I |
T1N0M0 |
Malignant |
| L14 |
190 |
M |
57 |
Larynx |
Squamous cell carcinoma of larynx |
3 |
IV |
T4N0M0 |
Malignant |
| L15 |
191 |
F |
47 |
Nose |
Squamous cell carcinoma of maxillary sinus |
3 |
I |
T1N0M0 |
Malignant |
| L16 |
192 |
M |
43 |
Nose |
Squamous cell carcinoma of left nasal cavity |
3 |
III |
T3N0M0 |
Malignant |
| M1 |
193 |
F |
56 |
Nasopharynx |
Squamous cell carcinoma of nasopharynx |
3 |
II |
T2N0M0 |
Malignant |
| M2 |
194 |
M |
56 |
Nasopharynx |
Squamous cell carcinoma of nasopharynx |
3 |
II |
T2N0M0 |
Malignant |
| M3 |
195 |
M |
62 |
Nasopharynx |
Squamous cell carcinoma of nasopharynx |
3 |
I |
T1N0M0 |
Malignant |
| M4 |
196 |
F |
36 |
Nose |
Squamous cell carcinoma of maxillary sinus |
3 |
II |
T2N0M0 |
Malignant |
| M5 |
197 |
M |
52 |
Larynx |
Squamous cell carcinoma of larynx |
3 |
III |
T3N0M0 |
Malignant |
| M6 |
198 |
M |
46 |
Larynx |
Squamous cell carcinoma of larynx |
3 |
III |
T3N0M0 |
Malignant |
| M7 |
199 |
M |
64 |
Larynx |
Squamous cell carcinoma of larynx |
3 |
II |
T2N0M0 |
Malignant |
| M8 |
200 |
M |
63 |
Larynx |
Squamous cell carcinoma of larynx |
3 |
III |
T3N0M0 |
Malignant |
. † For precise diagnosis, refer to pathology description.
**The grade 1-3 (or I-III) in Pathology Diagnosis is equivalent to well-differentiated, moderately-differentiated or poorly differentiated, respectively, under microscope.
*(for certain tumors), features are not significantly distinguishing to make it look any different from undifferentiated cancers which occur in other organs.
'-' - no staining; '+-' - borderline staining; '+' - weak staining; '++' - moderate staining; '+++' - strong staining; '%' - percentage of positive cells.
T0 - No evidence of primary tumor
Tis - Carcinoma in situ; intraepithelial or invasion of lamina propria
T3 - Tumor invades through muscularis propria into subserosa or into non-peritonealized pericolic or perirectal tissues.
T4 - Tumor directly invades other organs or structures and/or perforate visceral peritoneum